ERNA: Eterna Therapeutics Inc. Stock

by  •  • Comments Off on ERNA: Eterna Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 19.44
Enterprise Value ($M) 52.14
Book Value ($M) -45.39
Book Value / Share -0.88
Price / Book -0.43
NCAV ($M) -48.38
NCAV / Share -0.94
Price / NCAV -0.40

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.91
Return on Equity (ROE) -20.12

Liquidity (mrq)
Quick Ratio 0.48
Current Ratio 0.48

Balance Sheet (mrq) ($M)
Current Assets 4.73
Assets 7.72
Liabilities 53.11
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
6 days ago 13G/A Freebird Partners LP
2024-01-19 13G/A Singer Nicholas Jason 9.99 7.73

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPOR
2024-03-18 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1)
2024-03-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-03 229,927 485,025 47.41
2025-01-31 80,055 366,091 21.87
2025-01-30 223,748 1,150,095 19.45
2025-01-29 117,561 367,652 31.98
2025-01-28 45,913 194,149 23.65

(click for more detail)

Similar Companies
ENVB – Enveric Biosciences, Inc. EPIX – ESSA Pharma Inc.
EQ – Equillium, Inc. ESLA – Estrella Immunopharma, Inc.
EVOK – Evoke Pharma, Inc.


Financial data and stock pages provided by
Fintel.io